Search

everythinglearnresearchcommunity

for

Search:↓

Early intervention in patch-type alopecia may prevent progression to more severe forms by targeting immune pathways and preserving keratin.

Alopecia areata in children is caused by the immune system attacking hair follicles due to genetic factors.

Keratin 15 expression in skin cells is regulated by two mechanisms involving PKC/AP-1 and FOXM1.

α-Ketoglutaric acid improves hair growth, rabbit performance, and antioxidant levels.

The document explains how the immune system reacts to organ transplants and the treatments used to prevent rejection.

Forsythiasides have multiple health benefits but may cause pseudoallergic reactions, and more research is needed.

Exosome-based therapies show promise for treating alopecia areata but need more research.

Kangfuxin (KFX) extract speeds up wound healing and improves skin regeneration.

Natural compounds may help treat advanced papillary thyroid cancer by targeting specific molecular pathways.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Damage to skin releases dsRNA, which activates TLR3 and helps in skin and hair follicle regeneration.

New treatments for hair loss may target specific pathways and generate new hair follicles.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

The document explains how to create detailed biological pathways using genomic data and tools, with examples of hair and breast development.

Effective PCOS treatments require targeting specific signaling pathways.

Faulty inflammasome activation may lead to autoimmune skin diseases and could be a target for new treatments.

Traditional Chinese Medicine and biomaterials help heal chronic wounds by targeting multiple pathways.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Inhibiting AP1 in mice skin causes structural changes and weakens the skin barrier.

The mTOR pathway proteins are altered in the hair follicles of patients with Lichen Planopilaris and Frontal Fibrosing Alopecia.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Distinct miRNA signatures could help diagnose and treat severe Alopecia Areata.

Blocking JAK-STAT signaling can lead to hair growth.

JAK inhibitors show promise for treating skin diseases effectively and safely.

JAK inhibitors help treat alopecia areata but have high recurrence after stopping.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

Tofacitinib helped a woman regrow hair with no major side effects.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

Stem cells compete for space using cell adhesion, and mutations can affect their competitive success, with implications for tissue health and disease.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.